CFDB - Cystic Fibrosis DataBase

ongoing trials trial from www.clinicaltrials.gov

A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients With Cystic Fibrosis (CFmised, Double-blind, Parallel-group Study of Alginate Oligosaccharide) - Phase 2|Phase 3 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment

Participants

Cystic Fibrosis - 18 Years and older   (Adult, Older Adult)

Interventions

Drug: OligoG DPI

Outcome measures

FEV1 percent predicted|Pulmonary exacerbation rate

Keywords: pharmacological_intervention; Respiratory Tract Infections; Respiratory Tract Diseases; Infection; Bacterial Infections; oligoG; Airway clearance drugs -expectorants- mucolytic- mucociliary-; Respiratory System Agents;